Table of Contents Table of Contents
Previous Page  97 / 104 Next Page
Information
Show Menu
Previous Page 97 / 104 Next Page
Page Background

95

NCCN Guidelines for Patients

®

:

Ovarian Cancer, Version 1.2017

Acronyms

Acronyms

NCCN

®

National Comprehensive Cancer Network

®

AJCC

American Joint Committee on Cancer

AFP

alpha-fetoprotein

BEP

bleomycin, etoposide, and cisplatin

BSO

bilateral salpingo-oophorectomy

CA-125

cancer antigen 125

CAM

complementary and alternative medicine

CBC

complete blood count

CEA

carcinoembryonic antigen

cm

centimeter

CT

computed tomography

DNA

deoxyribonucleic acid

FDA

U.S. Food and Drug Administration

FIGO

International Federation of Gynecology and Obstetrics

FNA

fine-needle aspiration

GI

gastrointestinal

HNPCC

heredity non-polyposis colorectal cancer syndrome

IP

intraperitoneal

IV

intravenous

LCOH

less common ovarian histopathologies

LHRH

luteinizing hormone-releasing hormone

LMP

low malignant potential

mm

millimeter

MMMT

malignant mixed Müllerian tumor

MRI

magnetic resonance imaging

PARP

poly ADP-ribose polymerase

PET

positron emission tomography

PET/CT

positron emission tomography/computed tomography

TAH

total abdominal hysterectomy

TKI

tyrosine kinase inhibitor

USO

unilateral salpingo-oophorectomy